Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 6,687 | 6,245 | 5,952 | 14,241 | 12,581 |
| Gross Profit | 6,687 | 6,245 | 5,952 | 14,241 | 12,581 |
| Operating Expenses | 24,100 | 28,807 | 23,763 | 28,350 | 23,555 |
| Operating Income | -17,413 | -22,562 | -17,811 | -14,109 | -10,974 |
| Interest Expense | 198 | 309 | 429 | 482 | 506 |
| Other Income | 1,272 | 939 | 673 | 399 | 159 |
| Pre-tax Income | -16,339 | -21,932 | -17,567 | -14,192 | -11,321 |
| Income Tax | N/A | N/A | N/A | N/A | 4,444 |
| Net Income Continuous | -16,339 | -21,932 | -17,567 | -14,192 | -15,765 |
| Net Income | $-16,339 | $-21,932 | $-17,567 | $-14,192 | $-15,765 |
| EPS Basic Total Ops | -0.10 | -0.13 | -0.12 | -0.10 | -0.11 |
| EPS Basic Continuous Ops | -0.10 | -0.14 | -0.12 | -0.10 | -0.11 |
| EPS Diluted Total Ops | -0.10 | -0.13 | -0.12 | -0.10 | -0.11 |
| EPS Diluted Continuous Ops | -0.10 | -0.14 | -0.12 | -0.10 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.14 | -0.12 | N/A | N/A |
| EBITDA(a) | $-17,079 | $-22,255 | $-17,468 | $-13,726 | $-10,580 |